Khorashad et al., (2013) analyzed BCR-ABL kinase domain mutations in 1,700 samples by direct DNA sequencing and found that 11.4% CML patient samples harbored ≥2 mutations. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.